Not recruiting
Hepato-lenticular degeneration
Not recruitingStudy of Trientine Dihydrochloride (Cufence) to Evaluate Its Effects and Safety in Patients with Wilson's Disease
Registered drugNo placebo
Study of Trientine Dihydrochloride (Cufence) to Evaluate Its Effects and Safety in Patients with Wilson's Disease
Registered drugNo placebo
- Disease:Hepato-lenticular degeneration
- Substances:Trientine Dihydrochloride
Countries:
Denmark
Denmark- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Trientine Dihydrochloride



